Investing.com - Hyperfine reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Hyperfine announced earnings per share of $-0.190 on revenue of $2.35M. Analysts polled by Investing.com anticipated EPS of $-0.260 on revenue of $1.55M.
Hyperfine shares are down 28.35% from the beginning of the year, still down 95.30% from its 52 week high of $16.61 set on December 23, 2021.
Hyperfine follows other major Healthcare sector earnings this month
Hyperfine's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar